These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 8914854)

  • 1. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
    Powell PK; Wolf I; Lasker JM
    Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
    Powell PK; Wolf I; Jin R; Lasker JM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
    Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
    Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human liver lauric acid hydroxylase activities.
    Castle PJ; Merdink JL; Okita JR; Wrighton SA; Okita RT
    Drug Metab Dispos; 1995 Oct; 23(10):1037-43. PubMed ID: 8654190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4.
    Jin R; Koop DR; Raucy JL; Lasker JM
    Arch Biochem Biophys; 1998 Nov; 359(1):89-98. PubMed ID: 9799565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
    Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
    Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein.
    Kawashima H; Naganuma T; Kusunose E; Kono T; Yasumoto R; Sugimura K; Kishimoto T
    Arch Biochem Biophys; 2000 Jun; 378(2):333-9. PubMed ID: 10860550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
    Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
    Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
    Okita RT; Masters BS
    Drug Metab Dispos; 1980; 8(3):147-51. PubMed ID: 6104577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of steric bulk and conformational rigidity on fatty acid omega hydroxylation by a cytochrome P450 4A1 fusion protein.
    Bambal RB; Hanzlik RP
    Arch Biochem Biophys; 1996 Oct; 334(1):59-66. PubMed ID: 8837739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450.
    Imaoka S; Tanaka S; Funae Y
    Biochem Int; 1989 Apr; 18(4):731-40. PubMed ID: 2504167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4.
    Scheller U; Zimmer T; Kärgel E; Schunck WH
    Arch Biochem Biophys; 1996 Apr; 328(2):245-54. PubMed ID: 8645001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
    Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T
    Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of koala (Phascolarctos cinereus) liver cytochrome P450 CYP4A15.
    Ngo SN; McKinnon RA; Stupans I
    Gene; 2006 Jul; 376(1):123-32. PubMed ID: 16677781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme-coordinating analogs of lauric acid as inhibitors of fatty acid omega-hydroxylation.
    Lu P; Alterman MA; Chaurasia CS; Bambal RB; Hanzlik RP
    Arch Biochem Biophys; 1997 Jan; 337(1):1-7. PubMed ID: 8990261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxylation of lauramide diethanolamine by liver microsomes.
    Merdink J; Decosta K; Mathews JM; Jones CB; Okita JR; Okita RT
    Drug Metab Dispos; 1996 Feb; 24(2):180-6. PubMed ID: 8742229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA; Roman LJ; Miller RT; Masters BS
    Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhibitors on omega- and (omega-1)-hydroxylation of lauric acid by frog liver microsomes.
    Miura Y
    Lipids; 1982 Dec; 17(12):864-9. PubMed ID: 6984479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes.
    Clarke SE; Baldwin SJ; Bloomer JC; Ayrton AD; Sozio RS; Chenery RJ
    Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.